Is There A Genetic Basis to Atrial Fibrillation?

Size: px
Start display at page:

Download "Is There A Genetic Basis to Atrial Fibrillation?"

Transcription

1 Prior reports of familial AF Is There A Genetic Basis to Atrial Fibrillation? Patrick T. Ellinor, MD, PhD Cardiac Arrhythmia Service & Cardiovascular Research Center Massachusetts General Hospital, Harvard Medical School Original description of a family of three brothers with AF dates to Wolff, L. NEJM 229: Three families with AF have been mapped to a locus on chromosome 10. Brugada, R. et al., NEJM 336: Hypothesis MGH Lone AF Study Patients with lone atrial fibrillation may have a genetic contribution to their condition We determined the prevalence of atrial fibrillation in the family members of patients with lone atrial fibrillation Ongoing enrollment of a cohort of subjects with lone atrial fibrillation since 6/01 At enrollment subjects undergo a physical examination, detailed medical and family history. Results of ECHO, Holter, ECG, and basic laboratory studies are obtained. Blood samples for DNA and protein analyses ~700 probands and ~250 family members enrolled to date 1

2 Kindreds with multiple affected individuals Offspring AF risk by Parental h/o AF 100 AF 1 parent OR 1.9; (P=0.02) <75yo, w/o h/o heart disease OR 3.2; (P< 0.001) Fox Benjamin JAMA 2004;291:2851 4yr AF Risk/1,000 person yr Men Women Ellinor et al. Human Genetics HTN Diabetes Heart Disease Parent hx AF Atrial fibrillation in the general population is heritable Three broad genetic approaches to AF (or any other common disease) Iceland AF in a first degree relative confers a 1.77 RR of AF First degree relatives of those with AF under age 60 have risk of AF five times that of the general population (Arnar et al. Eur Heart J. 2006; 27(6): ) Danish Twins Study Concordance rate of AF in monozygotic vs. dizygotic twins was 22 vs 12%. Estimated heritability of 62% (Christopherson et al. Circ EP 2009) Traditional mapping and cloning Hypertrophic cardiomyopathy Candidate gene studies Ion channels in LQTS Association studies Case-control Whole genome association studies 2

3 FAF-1 Known genes within the Chr 6 locus 7 living individuals with documented AF, 2 with peripartum cardiomyopathy Age of onset ranging from years of age. KCNQ1 (I Ks ) Mutation Leading to AF Experimental approaches Notable features: -24 yrs of age mean onset -Prolonged QT -Three patients developed cardiomyopathy after AF Three broad strategies: Traditional mapping and cloning Candidate gene studies Association studies Gain of function mutation in KCNQ1 can lead to AF. Chen et al., Science Jan :

4 Connexin 40 (GJA5) mutations in lone AF Family AF pts that had surgical PV isolation 3 somatic & 1 germline mutation found 5 of 19 family members with AF Mutation in heart but not lymphocytes Gollob et al., NEJM 2006, 354: Age of onset 32 years (range 16-59) Longer QRS duration of 100 vs. 86 ms (p=0.009) Prolonged P wave duration on SAECG of 132 vs. 104 ms (p=0.01) None of the family members had a prolonged QT interval (422 ms for unaffected vs. 424 ms for affected individuals) Mutation in S3 of KCNQ1 leads to AF Mutation in S3 of KCNQ1 leads to AF Das et al. Heart Rhythm,

5 Failure to deactivate in S209P mutation Ion channel mutations are rare in lone AF Screened lone AF cohort for mutations in: NPPA KCNQ1 Das et al. Heart Rhythm, KCNQ1 1 SCN5A 1 KCNE KCNA5 0 KCNJ2 0 GJA5 0 Ellinor et al. Heart 2004;90: Ellinor et al. BMC Med. Genetics Unpublished data GJA5/ Connexin 40 Lone AF SCN5A KCNE KCNA5 KCNJ2 Problems in the genetic dissection of AF Evaluate other families AF can be asymptomatic and/or paroxysmal AF is common in general population Phenotypic and genetic heterogeneity Genetic models are limited Mutations identified to date are not typical of patients seen in the office 5

6 Possible endophenotypes of AF BNP levels are elevated in both paroxysmal and chronic AF A Echocardiography Holter SA ECG - P wave alternans MRI - pulmonary venous or atrial abnormalities Plasma - ANP, BNP, Endothelin, CRP nt-probnp (fmol/ml) p= p= p=0.75 p= Controls PAF: SB or NSR PAF: AF or AFl Permanent AF Ellinor et al. JACC Experimental approaches Simple versus complex traits Three broad strategies: Traditional mapping and cloning Candidate gene studies Association studies Simple Complex Examples HCM, FH, LQTS HTN, CAD, AF Disease prevalence Rare Common Genes involved Single Many Frequency of genetic variant Rare / mutation Effect on protein function Severe Mild Common / polymorphism Effect on phenotype Large / causative Small / susceptibility 6

7 Genome Wide Association Studies (GWAS) Genome wide association study Use large population with AF vs controls. AF No AF Compare 300,000 to 1 million single nucleotide polymorphisms (SNPs) throughout the genome. Look for regions shared by those with AF but not in those without AF. Recently used to study repolarization, macular degeneration, diabetes, premature coronary disease, prostate cancer. Genetic variant more common in those with AF Genome wide association study 2/3 Genome wide association study 3/3 Identify top hits Replicate in additional populations Fingerprint each individual Pfeufer et al, Nature Genetics,

8 GWAS identifies common variants for AF on 4q25 Risk of AF with rs Iceland Study populations rs T Allelic Frequency Case Cont. OR [95% c.i.] P value 3 Total of 7,088 subjects with AF & 31,429 controls Discovery (550/4,476) [1.54, 2.21] 2.0x10-11 Replication (2,251/13,238) [1.49, 1.81] 2.7x10-23 Combined (2,801/17,714) [1.53, 1.83] 1.9x10-30 Other European ancestry Sweden (143/738) [1.38, 2.93] Odds Ratio 2 1 US - MGH (636/804) [1.51, 2.23] 9.8x10-10 Combined [1.58, 2.23] 1.1x10-12 All combined 0 Iceland Massachusetts General Hospital Sweden Hong Kong Fram ingham Heart Study Rotterdam Study German AF Network Vanderbilt AF Registry Combined [1.58, 1.84] 6.1x10-41 Gudbjartsson et al. Nature, Kääb Ellinor, Eur Heart J, 2009 Fine mapping of Chr 4q25 locus for AF Regional plot of Chr 4q25 locus for AF MGH AFNet Stage Discovery Replication Affection status AF No AF AF No AF Number 790 1,177 2,145 4,073 Age (yrs) 63 ± ± ± ± 12 Men 547 (69) 627 (53) 1,564 (73) 2,005 (49) Hypertension 383 (49) 670 (57) 1,148 (56) 730 (18) 8

9 After adjustment for rs Protective region for AF Combination of SNPs predicts large risk of AF How do variants at 4q25 lead to AF? Non-coding variants in a genomic desert. Closest gene is PITX2. One isoform, Pitx2c: Critical for left/right asymmetry Including specification of the left atrium and pulmonary myocardium Suppresses a default program for sinoatrial node formation in the left atrium Mommersteeg et al,

10 No relationship between rs genotype and PITX2 RNA levels Where are we headed? Integrate clinical, pharmacologic, and outcome data with genetic variation. Association between variants at 4q25 ischemic and cryptogenic stroke (Gretarsdottir S et al., Ann Neurol Oct;64(4):402-9.) Larger genetic studies with greater power Left atrial tissue from 51 transplant donors AF Gen Consortium Performed Three Analyses for Early Onset AF, Community AF, and PR interval AGES: Age, Gene, Environment Susceptibility ARIC: Atherosclerosis Risk in Communities Study CHS: Cardiovascular Health Study Cleveland Clinic decode genetics FHS: Framingham Heart Study RS: Rotterdam Study GHS: Gutenberg Heart Study MONICA/KORA/German AF Network MGH: Massachusetts General Hospital SHIP: Study of Health in Pomerania WGHS: Women s Genome Health Study Goal is to perform GWAS data for AF and the PR interval: AF: ~8,500 with AF & ~85,000 without AF PR: ~28,000 subjects Cases/ Controls AF Early-Onset AF Community AF PR interval 1,335 /12,844 Prevalent; No structural heart disease 896 prevalent / 15,629 controls 2,712 incident / 23,220 controls Incident/Prevalent - 28,517 subjects 10

11 GWAS of AF in the community: Chr 4q25 strongly associated with AF SNPs on Chr 16 within ZFHX3 are associated with AF in the community. Replicated in German AFNET Study Benjamin et al. Nature Genetics, 2009 Overall RR 1.25; P= 1.8x10-15 What do we know about ZFHX3? Future Directions for AF Regulates myogenic and neuronal differentiation Tumor suppressor gene in multiple cancers Susceptibility to Kawasaki disease Function in cardiac tissue unknown decode found no associations between rs t with 2 ZFHX3 expression probes blood & adipose tissue Identify other genetic loci for AF Examine gene-environment interactions such as age, sex, HTN Determine if identified variants are associated with outcomes such as stroke, heart failure and death. Develop animal models of identified genes for AF Berry J Biol. Chem 2001;276:25057 Sun,X., et al., Nat. Genet. 2005;37:407 Gudbjartsson Nat Genet 2009; epub Jung Development2005;132:5137 Burgner PLoS. Genet. 2009;5:e Slide courtesy of Emelia Benjamin 11

12 Conclusions Acknowledgements AF and particularly lone AF are heritable Mutations have been identified in a number of ion channels, but are rare causes of AF Genome wide association study has identified common variants on Chr 4q25 and 16 strongly associated with AF. Framingham Heart Study Emelia J. Benjamin Renate Schnabel Kathryn L. Lunetta Rotterdam Study Jacqueline Witteman Charlotte van Noord Cardiovascular Health Study Susan Heckbert Ken Rice Vanderbilt University Dawood Darbar Dan M. Roden German AF Network Arne Pfeufer Moritz F. Sinner Martina Muller Stefan Kääb AGES Albert Smith Vilmundur Gudnason ARIC Alvaro Alonso Dan Arking Cleveland Clinic Mina Chung John Barnard MGH Steve Lubitz Seiko Makino Saumya Das David J. Milan Jeremy N. Ruskin Cardiac Arrhythmia Service at MGH 12

Genetics of Atrial Fibrillation: does it help in treatment decisions?

Genetics of Atrial Fibrillation: does it help in treatment decisions? Genetics of Atrial Fibrillation: does it help in treatment decisions? Atrial fibrillation Pathophysiology of atrial fibrillation (AF) Genetic loci identified for AF Role in therapy outcome ardiologie Molecular

More information

EHRA/EUROPACE 2011 Madrid, Spain June

EHRA/EUROPACE 2011 Madrid, Spain June EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different

More information

Is Atrial Fibrillation preventable?

Is Atrial Fibrillation preventable? Heart Rhythm Congress, Birmingham, 11 th October 2016 Is Atrial Fibrillation preventable? The interplay between genetic and environmental factors in genesis of AF Andrew Grace University of Cambridge -

More information

Causes and Triggers of Atrial Fibrillation.

Causes and Triggers of Atrial Fibrillation. AFA Patient Day, Birmingham, October 18th 2009 Causes and Triggers of Atrial Fibrillation. Andrew Grace Papworth Hospital and Cambridge University Causes of Atrial Fibrillation are changing. AF is a more

More information

Genetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic.

Genetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic. Genetics of Sudden Cardiac Death Geoffrey Pitt Ion Channel Research Unit Duke University Disclosures: Grant funding from Medtronic Duke U N I V E R S I T Y Sudden Cardiac Death High incidence 50-100 per

More information

A rare variant in MYH6 confers high risk of sick sinus syndrome. Hilma Hólm ESC Congress 2011 Paris, France

A rare variant in MYH6 confers high risk of sick sinus syndrome. Hilma Hólm ESC Congress 2011 Paris, France A rare variant in MYH6 confers high risk of sick sinus syndrome Hilma Hólm ESC Congress 2011 Paris, France Disclosures I am an employee of decode genetics, Reykjavik, Iceland. Sick sinus syndrome SSS is

More information

Role of micro-rnas in Atrial Fibrillation

Role of micro-rnas in Atrial Fibrillation Role of micro-rnas in Atrial Fibrillation Amir Shaikh, MD; David D McManus, MD,ScM Assistant Professor, Department of Medicine University of Massachusetts Medical School, Worcester, MA, USA Disclosures

More information

Epidemiology of Atrial Fibrillation CA Heart Rhythm Symposium September 25, Epidemiology. Atrial Fibrillation

Epidemiology of Atrial Fibrillation CA Heart Rhythm Symposium September 25, Epidemiology. Atrial Fibrillation Epidemiology of CA Heart Rhythm Symposium September 25, 29 The NHLBI s Framingham Heart Study Boston University School of Medicine No industry relationships to disclose 1R1HL92577 An Epidemiologist s Perspective

More information

Atrial fibrillation (AF) is the most common arrhythmic disorder, Compendium. Emerging Directions in the Genetics of Atrial Fibrillation

Atrial fibrillation (AF) is the most common arrhythmic disorder, Compendium. Emerging Directions in the Genetics of Atrial Fibrillation Compendium Circulation Research Compendium on Atrial Fibrillation: Atrial Fibrillation Compendium: Historical Context and Detailed Translational Perspective on an Important Clinical Problem The Clinical

More information

ICD in a young patient with syncope

ICD in a young patient with syncope ICD in a young patient with syncope Konstantinos P. Letsas, MD, FESC Second Department of Cardiology Evangelismos General Hospital of Athens Athens, Greece Case presentation A 17-year-old apparently healthy

More information

Noninvasive Predictors of Sudden Cardiac Death

Noninvasive Predictors of Sudden Cardiac Death 2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial

More information

Name of Presenter: Marwan Refaat, MD

Name of Presenter: Marwan Refaat, MD NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 I have no actual or potential conflict of interest in relation

More information

Clinical and Genetic Epidemiology Winter School Personalized Medicine in Cardiology Rhythmology as an Example

Clinical and Genetic Epidemiology Winter School Personalized Medicine in Cardiology Rhythmology as an Example Clinical and Genetic Epidemiology Winter School 06.02.2017 17.02.2017 Personalized Medicine in Cardiology Rhythmology as an Example Stefan Kääb LMU-Klinikum Großhadern Medizinische Klinik und Poliklinik

More information

Genetic testing in Cardiomyopathies

Genetic testing in Cardiomyopathies Genetic testing in Cardiomyopathies Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University School of Medicine, New York, USA and Molecular Cardiology, IRCCS Fondazione

More information

Circulation Topic Review

Circulation Topic Review Circulation Topic Review Genetic Epidemiology in Circulation and the Circulation Subspecialty Journals The Editors The following articles are being highlighted as part of Circulation s Topic Review series.

More information

Basics of Structure/Function of Sodium and Potassium Channels Barry London, MD PhD

Basics of Structure/Function of Sodium and Potassium Channels Barry London, MD PhD Basics of Structure/Function of Sodium and Potassium Channels Barry London, MD PhD University of Pittsburgh Medical Center Pittsburgh, PA International Symposium of Inherited Arrhythmia Disorders and Hypertrophic

More information

Atrial fibrillation in Cardiac Channelopathies

Atrial fibrillation in Cardiac Channelopathies Atrial fibrillation in Cardiac Channelopathies Thejus, Jayachandran Francis, Johnson Introduction Atrial fibrillation is the commonest arrhythmia encountered in day-to-day clinical practice. Its prevalence

More information

Declaration of conflict of interest. I have nothing to disclose.

Declaration of conflict of interest. I have nothing to disclose. Declaration of conflict of interest I have nothing to disclose. Left Bundle branch block in HF: DO GENETICS MATTER? Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University

More information

Journal of Translational Medicine. Open Access RESEARCH

Journal of Translational Medicine. Open Access RESEARCH DOI 10.1186/s12967-017-1170-3 Journal of Translational Medicine RESEARCH Open Access Association of atrial fibrillation susceptibility genes, atrial fibrillation phenotypes and response to catheter ablation:

More information

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes RHEA C. PIMENTEL, MD, FACC, FHRS UNIVERSITY OF KANSAS HOSPITAL MID AMERICA CARDIOLOGY AUGUST 19, 2012 Monogenic Arrhythmia Syndromes Mendelian

More information

Strength and weakness of genetic testing in clinical routine.

Strength and weakness of genetic testing in clinical routine. Strength and weakness of genetic testing in clinical routine. Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular

More information

Sudden cardiac death: Primary and secondary prevention

Sudden cardiac death: Primary and secondary prevention Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)

More information

Pharmacogenomics of Drug-Induced Conditions

Pharmacogenomics of Drug-Induced Conditions Pharmacogenomics of Drug-Induced Conditions Dan M. Roden, M.D. Professor of Medicine and Pharmacology Director, Oates Institute for Experimental Therapeutics Assistant Vice-Chancellor for Personalized

More information

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and

More information

Atrial Cardiomyopathy is it relevant?

Atrial Cardiomyopathy is it relevant? Atrial Cardiomyopathy is it relevant? Dr Carl Shakespeare MD FRCP FACC FESC Consultant Cardiologist Relevance Progressive nature of AF Implications for RF Targeting Risk Factors CHADS vasc scoring? Could

More information

Interventional solutions for atrial fibrillation in patients with heart failure

Interventional solutions for atrial fibrillation in patients with heart failure Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department

More information

Genetics and Genomics in Medicine Chapter 8 Questions

Genetics and Genomics in Medicine Chapter 8 Questions Genetics and Genomics in Medicine Chapter 8 Questions Linkage Analysis Question Question 8.1 Affected members of the pedigree above have an autosomal dominant disorder, and cytogenetic analyses using conventional

More information

The State of the Molecular Autopsy for Sudden Death in the Young

The State of the Molecular Autopsy for Sudden Death in the Young The State of the Molecular Autopsy for Sudden Death in the Young Michael J. Ackerman, MD, PhD Windland Smith Rice Cardiovascular Genomics Research Professor Professor of Medicine, Pediatrics, and Pharmacology

More information

Dan Koller, Ph.D. Medical and Molecular Genetics

Dan Koller, Ph.D. Medical and Molecular Genetics Design of Genetic Studies Dan Koller, Ph.D. Research Assistant Professor Medical and Molecular Genetics Genetics and Medicine Over the past decade, advances from genetics have permeated medicine Identification

More information

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation 48 th Annual New York Cardiovascular Symposium Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation Is Left Atrial Appendage Dysfunction Sufficient to Generate Clots? December

More information

Journal of the American College of Cardiology Vol. 55, No. 8, by the American College of Cardiology Foundation ISSN /10/$36.00 Publ

Journal of the American College of Cardiology Vol. 55, No. 8, by the American College of Cardiology Foundation ISSN /10/$36.00 Publ Journal of the American College of Cardiology Vol. 55, No. 8, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.11.041

More information

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases Hereditary Cardiovascular Conditions genetic testing for undiagnosed diseases What is Hypertrophic Cardiomyopathy (HCM)? normal heart heart with hcm Extra or thick heart muscle Typically in the left ventricle

More information

Preventing Sudden Death in Young Athletes. Outline. Scope of the Problem. Causes of SCD in Young Athletes. Sudden death in the young athlete

Preventing Sudden Death in Young Athletes. Outline. Scope of the Problem. Causes of SCD in Young Athletes. Sudden death in the young athlete Preventing Sudden Death in Young Athletes Ronn E. Tanel, MD Director, Pediatric Arrhythmia Service UCSF Children s Hospital Associate Professor of Pediatrics UCSF School of Medicine Outline Sudden death

More information

Gender Differences in Atrial Fibrillation Risk Factors and Disease Onset Gender in Medicine Congress

Gender Differences in Atrial Fibrillation Risk Factors and Disease Onset Gender in Medicine Congress Gender Differences in Atrial Fibrillation Risk Factors and Disease Onset Gender in Medicine Congress Renate B. Schnabel, MD, MSc Berlin, September 22, 2015 Gender Differences in Atrial Fibrillation Risk

More information

Steel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015

Steel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015 Steel vs Alcohol Or Neither Management of Hypertrophic Cardiomyopathy Josh Doll, MD January 24, 2015 47yo Male, Mr. L Severe progressive dyspnea on exertion and weight gain Previous avid Cross-Fit participant

More information

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation 25 October 2008 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor

More information

Rebuttal. Jerónimo Farré MD 2010

Rebuttal. Jerónimo Farré MD 2010 Rebuttal 1.We do not know what are the types of AF in which ablation is worthless or most effective 2.Waiting implies to consider the ablation at an older age and when the duration of the history of AF

More information

ATRIAL FIBRILLATION AND ETHNICITY. Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE)

ATRIAL FIBRILLATION AND ETHNICITY. Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE) ATRIAL FIBRILLATION AND ETHNICITY Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE) Atrial fibrillation (AF) and ethnicity The known The unknown The paradox Why

More information

Controversies in Risk Stratification

Controversies in Risk Stratification Controversies in Risk Stratification Things are not as simple as they seem Banff 2017 2015 MFMER 3494750-5 Relative importance Triggers vs Substrate in Pathophysiology of AF AF burden Paroxysmal? Persistent?

More information

What s new in my specialty?

What s new in my specialty? What s new in my specialty? Jon Melman, MD Heart Rhythm Specialists McKay-Dee Hospital some would say some would say my specialty 1 some would say my specialty First pacemaker 1958 some would say my specialty

More information

Introduction to Genetics and Genomics

Introduction to Genetics and Genomics 2016 Introduction to enetics and enomics 3. ssociation Studies ggibson.gt@gmail.com http://www.cig.gatech.edu Outline eneral overview of association studies Sample results hree steps to WS: primary scan,

More information

Atrial Fibrillation and Sleep Apnea. Farhat S. Khairallah, MD, FHRS, FACC

Atrial Fibrillation and Sleep Apnea. Farhat S. Khairallah, MD, FHRS, FACC Atrial Fibrillation and Sleep Apnea Farhat S. Khairallah, MD, FHRS, FACC The art of medicine consists in amusing the patient while nature cures the disease. Voltaire Classification of AF Paroxysmal AF

More information

Prolonged QT Syndromes: Congenital and Acquired

Prolonged QT Syndromes: Congenital and Acquired Prolonged QT Syndromes: Congenital and Acquired April 30, 2014 Elizabeth S. Kaufman, MD I have no financial disclosures. MetroHealth Campus, Case Western Reserve University Prolonged QT Syndromes Congenital

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

Discordant Atrial Natriuretic Peptide and Brain Natriuretic Peptide Levels in Lone Atrial Fibrillation

Discordant Atrial Natriuretic Peptide and Brain Natriuretic Peptide Levels in Lone Atrial Fibrillation Journal of the American College of Cardiology Vol. 45, No. 1, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.09.045

More information

Sudden Cardiac Death and Asians Disclosures

Sudden Cardiac Death and Asians Disclosures Sudden Cardiac Death and Asians Disclosures 7 February 2009 Asian Heart and Vascular Symposium None Zian H. Tseng, M.D., M.A.S. Assistant Professor of Medicine Cardiac Electrophysiology Section University

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

La valutazione dell atleta: è una strategia salva-vita e costo-efficace? La valutazione dell atleta: è una strategia salva-vita e costo-efficace? Primo trattato di Medicina Wilson and Jungner s criteria In the 1960s the World Health Organization adopted the Wilson and Jungner

More information

The Future. Sanjiv M. Narayan, MD, PHD, FHRS, FRCP Professor of Medicine, University of California San Diego San Diego Veterans Affairs Medical Center

The Future. Sanjiv M. Narayan, MD, PHD, FHRS, FRCP Professor of Medicine, University of California San Diego San Diego Veterans Affairs Medical Center The Future Sanjiv M. Narayan, MD, PHD, FHRS, FRCP Professor of Medicine, University of California San Diego San Diego Veterans Affairs Medical Center Disclosures: Funded by NIH (HL70529, HL83359, HL103800,

More information

Cardiac Arrhythmias. Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company

Cardiac Arrhythmias. Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company Cardiac Arrhythmias Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company The Cardiovascular System Three primary functions Transport of oxygen, nutrients, and hormones to

More information

Introduction to the Genetics of Complex Disease

Introduction to the Genetics of Complex Disease Introduction to the Genetics of Complex Disease Jeremiah M. Scharf, MD, PhD Departments of Neurology, Psychiatry and Center for Human Genetic Research Massachusetts General Hospital Breakthroughs in Genome

More information

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden

More information

Samer Nasr, M.D. Mount Lebanon Hospital.

Samer Nasr, M.D. Mount Lebanon Hospital. Samer Nasr, M.D. Mount Lebanon Hospital. Lone atrial fibrillation: Younger than 60 years old. No clinical or echo evidence of cardiopulmonary disease. Favorable prognosis. Thromboembolism usually not

More information

The Clinical Utility of Genetic Data in CVD

The Clinical Utility of Genetic Data in CVD Stanley S Wang MD JD MPH Clinical Cardiologist, Austin Heart Adjunct Assistant Professor of Medicine University of North Carolina School of Medicine Chapel Hill, NC INTRODUCTION At the American Heart Association

More information

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Hanne Rasmusen Consultant cardiologist, PhD Dept. of Cardiology Bispebjerg University Hospital

More information

Genomics and Cardiac Arrhythmias

Genomics and Cardiac Arrhythmias Journal of the American College of Cardiology Vol. 47, No. 1, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.08.059

More information

Defining Sub-Clinical Atrial Fibrillation and its management

Defining Sub-Clinical Atrial Fibrillation and its management Defining Sub-Clinical Atrial Fibrillation and its management Jeff Healey MD, MSc, FRCP, FHRS PHRI Chair in Cardiology Research Population Health Research Institute McMaster University, Canada Sub-Clinical

More information

Stroke is the second leading cause of mortality worldwide, Clinical Sciences

Stroke is the second leading cause of mortality worldwide, Clinical Sciences Clinical Sciences Twelve Single Nucleotide Polymorphism Genetic Risk Score Identifies Individuals at Increased Risk for Future Atrial Fibrillation and Stroke Hayato Tada, MD*; Dov Shiffman, PhD*; J. Gustav

More information

Invasive Risk Stratification: When is it needed?

Invasive Risk Stratification: When is it needed? Inherited Cardiomyopathies and Channelopathies: Who is at risk for Sudden Cardiac Death? Invasive Risk Stratification: When is it needed? Hung-Fat Tse, MD, PhD Department of Medicine The University of

More information

Inherited Arrhythmia Syndromes

Inherited Arrhythmia Syndromes Inherited Arrhythmia Syndromes When to perform Genetic testing? Arthur AM Wilde February 4, 2017 Which pts should undergo genetic testing? SCD victims with a likely diagnosis Pts diagnosed with an inherited

More information

ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ ΟΓΕΝΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΓΙΑ ΤΙΣ ΔΙΑΥΛΟΠΑΘΕΙΕΣ

ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ ΟΓΕΝΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΓΙΑ ΤΙΣ ΔΙΑΥΛΟΠΑΘΕΙΕΣ ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ ΟΓΕΝΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΓΙΑ ΤΙΣ ΔΙΑΥΛΟΠΑΘΕΙΕΣ ΣΤΕΛΙΟΣ ΠΑΡΑΣΚΕΥΑÏΔΗΣ ΔΙΕΥΘΥΝΤΗΣ ΕΣΥ Α Καρδιολογική Κλινική ΑΠΘ, Νοσοκομείο ΑΧΕΠΑ, Θεσσαλονίκη NO CONFLICT OF INTEREST Sudden Cardiac Death

More information

Is There a Genomic Basis to Acquired Channelopathic disease

Is There a Genomic Basis to Acquired Channelopathic disease Is There a Genomic Basis to Acquired Channelopathic disease Yaniv Bar-Cohen, M.D. Associate Professor of Pediatrics Division of Cardiology / Electrophysiology Children s Hospital Los Angeles Keck School

More information

AHERITABLE COMPONENT UNderlying

AHERITABLE COMPONENT UNderlying ORIGINAL CONTRIBUTION Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation Steven A. Lubitz, MD, MH Xiaoyan Yin, hd João D. Fontes, MD Jared W. Magnani, MD Michiel

More information

# For the GWAS stage, B-cell NHL cases which small numbers (N<20) were excluded from analysis.

# For the GWAS stage, B-cell NHL cases which small numbers (N<20) were excluded from analysis. Supplementary Table 1a. Subtype Breakdown of all analyzed samples Stage GWAS Singapore Validation 1 Guangzhou Validation 2 Guangzhou Validation 3 Beijing Total No. of B-Cell Cases 253 # 168^ 294^ 713^

More information

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018 Atrial Fibrillation and the NOAC s John Raymond MS, PA-C, MHP February 10, 2018 Pathogenesis EPIDEMIOLOGY Arrhythmia-related hospitalisations in the US Ventricular fibrillation 2% Atrial fibrillation 34%

More information

Office ECG Interpretation

Office ECG Interpretation Office ECG Interpretation Jason Evanchan, DO Assistant Professor of Medicine Division of Cardiovascular Medicine The Ohio State University Wexner Medical Center Outline of topics High risk ischemia T wave

More information

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Arrhythmias (II) Ventricular Arrhythmias. Disclosures Arrhythmias (II) Ventricular Arrhythmias Amy Leigh Miller, MD, PhD Cardiovascular Electrophysiology, Brigham & Women s Hospital Disclosures None Rhythms and Mortality Implantable loop recorder post-mi

More information

Additional Disclosure

Additional Disclosure Additional Disclosure The Genetics of Prostate Cancer: Clinical Implications William J. Catalona, MD Collaborator with decode genetics, Inc. Non-paid consultant with no financial interest or support Northwestern

More information

Pearls of the ESC/ERS Guidelines 2015 Channelopathies

Pearls of the ESC/ERS Guidelines 2015 Channelopathies Pearls of the ESC/ERS Guidelines 2015 Channelopathies Carina Blomstrom Lundqvist Dept Cardiology, Uppsala, Sweden Content 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias

More information

Quantitative genetics: traits controlled by alleles at many loci

Quantitative genetics: traits controlled by alleles at many loci Quantitative genetics: traits controlled by alleles at many loci Human phenotypic adaptations and diseases commonly involve the effects of many genes, each will small effect Quantitative genetics allows

More information

CS2220 Introduction to Computational Biology

CS2220 Introduction to Computational Biology CS2220 Introduction to Computational Biology WEEK 8: GENOME-WIDE ASSOCIATION STUDIES (GWAS) 1 Dr. Mengling FENG Institute for Infocomm Research Massachusetts Institute of Technology mfeng@mit.edu PLANS

More information

Family stories: to illustrate inheritance and the impact on families. Dr Claire Turner Consultant clinical geneticist

Family stories: to illustrate inheritance and the impact on families. Dr Claire Turner Consultant clinical geneticist Family stories: to illustrate inheritance and the impact on families Dr Claire Turner Consultant clinical geneticist Overview With respect to inherited cardiac conditions Simple modes of inheritance (Mendelian)

More information

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers ! Sudden cardiac death in the adult Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel.! " # $ % Cancers National Vital Statistics Report, Vol 49 (11), Oct. 12, 2001. 20% 25% State-specific

More information

ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES

ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES Isabelle C Van Gelder University Medical Center Groningen The Netherlands ESC stroke council Prague January

More information

The genetics of complex traits Amazing progress (much by ppl in this room)

The genetics of complex traits Amazing progress (much by ppl in this room) The genetics of complex traits Amazing progress (much by ppl in this room) Nick Martin Queensland Institute of Medical Research Brisbane Boulder workshop March 11, 2016 Genetic Epidemiology: Stages of

More information

Atrial fibrillation: a key determinant in the cardiovascular risk continuum. u Prof. Joseph S. Alpert u Arizona, USA

Atrial fibrillation: a key determinant in the cardiovascular risk continuum. u Prof. Joseph S. Alpert u Arizona, USA Atrial fibrillation: a key determinant in the cardiovascular risk continuum u Prof. Joseph S. Alpert u Arizona, USA Disclosures u No major conflicts of interest: all honoraria

More information

Case Demonstrations in Congenital and Acquired Long QT Syndrome

Case Demonstrations in Congenital and Acquired Long QT Syndrome Case Demonstrations in Congenital and Acquired Long QT Syndrome Can You Make A Correct ECG Interpretation? Li Zhang, MD; 1-2 G. Michael Vincent, MD 1 1. LQTS Studies, Department t of Medicine i LDS Hospital,

More information

Genetics of Arterial and Venous Thrombosis: Clinical Aspects and a Look to the Future

Genetics of Arterial and Venous Thrombosis: Clinical Aspects and a Look to the Future Genetics of Arterial and Venous Thrombosis: Clinical Aspects and a Look to the Future Paul M Ridker, MD Eugene Braunwald Professor of Medicine Harvard Medical School Director, Center for Cardiovascular

More information

Key determinants of pathogenicity

Key determinants of pathogenicity Key determinants of pathogenicity Session 6: Determining pathogenicity and genotype-phenotype correlation J. Peter van Tintelen MD PhD Clinical geneticist Academic Medical Center Amsterdam, the Netherlands

More information

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States Srinivas R. Dukkipati, MD Co-Director, Cardiac Arrhythmia Service The Mount

More information

SUPPLEMENTARY INFORMATION. Meta-analyses of genome-wide association studies identify multiple novel loci related to pulmonary function

SUPPLEMENTARY INFORMATION. Meta-analyses of genome-wide association studies identify multiple novel loci related to pulmonary function SUPPLEMENTARY INFORMATION Meta-analyses of genome-wide association studies identify multiple novel loci related to pulmonary function Dana B. Hancock, 1,29 Mark Eijgelsheim, 2,29 Jemma B. Wilk, 3,29 Sina

More information

ARIC Manuscript Proposal #2099. PC Reviewed: 3/12/13 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #2099. PC Reviewed: 3/12/13 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal #2099 PC Reviewed: 3/12/13 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Utility of biomarker panel, hstnt, NT-proBNP, and cystatin C to prediction of

More information

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics Dysrhythmias CYDNEY STEWART MD, FACC NOVEMBER 3, 2017 Disclosures None 3 reasons to evaluate and treat dysrhythmias Eliminate symptoms and improve hemodynamics Prevent imminent death/hemodynamic compromise

More information

IS ATRIAL FIBRILLATION THE NEXT TYPE 2 DIABETES?

IS ATRIAL FIBRILLATION THE NEXT TYPE 2 DIABETES? IS ATRIAL FIBRILLATION THE NEXT TYPE 2 DIABETES? ROBERT M PEPPER, DO, FAAFP ASSISTANT DEAN PREDOCTORAL CLINICAL EDUCATION WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE IS ATRIAL FIBRILLATION THE NEXT TYPE

More information

Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada

Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada Άννα Κωστοπούλου Επιμελήτρια Α Ωνάσειο Καρδιοχειρουργικό Κέντρο Τμήμα Ηλεκτροφυσιολογίας και Βηματοδότησης BrS: Diagnosis 5:10000 First described

More information

Left atrial Function In Echocardiography

Left atrial Function In Echocardiography Left atrial Function In Echocardiography Pr Erwan DONAL erwan.donal@chu-rennes.fr Inserm Diastole LA Pressure (mmhg) -t/ 17 LA function 15 A-Loop 13 V-Loop 11 9 7 5 1 2 3 4 20 30 40 50 60 70 LA Volume

More information

An Introduction to Quantitative Genetics I. Heather A Lawson Advanced Genetics Spring2018

An Introduction to Quantitative Genetics I. Heather A Lawson Advanced Genetics Spring2018 An Introduction to Quantitative Genetics I Heather A Lawson Advanced Genetics Spring2018 Outline What is Quantitative Genetics? Genotypic Values and Genetic Effects Heritability Linkage Disequilibrium

More information

Adult Complexities of the Channelopathies

Adult Complexities of the Channelopathies Adult Complexities of the Channelopathies Andrew Krahn MD FHRS Sauder Family and Heart and Stroke Foundation Chair in Cardiology Paul Brunes Chair in Heart Rhythm Disorders University of British Columbia

More information

MULTIFACTORIAL DISEASES. MG L-10 July 7 th 2014

MULTIFACTORIAL DISEASES. MG L-10 July 7 th 2014 MULTIFACTORIAL DISEASES MG L-10 July 7 th 2014 Genetic Diseases Unifactorial Chromosomal Multifactorial AD Numerical AR Structural X-linked Microdeletions Mitochondrial Spectrum of Alterations in DNA Sequence

More information

Targeting the late sodium channel: A new antiarrhythmic paradigm?

Targeting the late sodium channel: A new antiarrhythmic paradigm? Targeting the late sodium channel: A new antiarrhythmic paradigm? Wojciech Zareba, MD, PhD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY Disclosures: - Gilead Sciences:

More information

Declaration of conflict of interest. None to declare

Declaration of conflict of interest. None to declare Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece

More information

Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification

Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification Class I Na Channel Blockers Flecainide Propafenone Class III K channel Blockers Dofetilide,

More information

State of the Molecular Autopsy

State of the Molecular Autopsy State of the Molecular Autopsy Michael J. Ackerman, MD, PhD Windland Smith Rice Cardiovascular Genomics Research Professor Professor of Medicine, Pediatrics, and Pharmacology Director, Long QT Syndrome/Genetic

More information

I have nothing to disclose. Research support from: Cardiac Risk in The Young

I have nothing to disclose. Research support from: Cardiac Risk in The Young I have nothing to disclose. Research support from: Cardiac Risk in The Young Pre-participation screening of Young Athletes: Current Perspective Professor Sanjay Sharma Disclosures: None SCD in Young Athletes

More information

Athletes with cardiac disease; dead and buried or chance for resurrection?

Athletes with cardiac disease; dead and buried or chance for resurrection? Athletes with cardiac disease; dead and buried or chance for resurrection? EuroPRevent 2011 Geneva F. Carré University Rennes 1-Pontchaillou Hospital Inserm U642, Rennes - F-35000 Risk of physical activity

More information

LES NOUVEAUX TROUBLES DE CONDUCTION HEREDITAIRES

LES NOUVEAUX TROUBLES DE CONDUCTION HEREDITAIRES LES NOUVEAUX TROUBLES DE CONDUCTION HEREDITAIRES Alban Baruteau L institut du thorax, INSERM 1087 CNRS 6291 IRS Université de Nantes Centre Chirurgical Marie Lannelongue M3C Université Paris Sud Le Kremlin

More information

Cardiovascular Genomics in 2007: Careers in Genomics and Proteomics

Cardiovascular Genomics in 2007: Careers in Genomics and Proteomics Cardiovascular Genomics in 2007: Careers in Genomics and Proteomics Christopher J. O Donnell MD MPH No Disclosures ACC How to Become a Cardiovascular Investigator November 9, 2007 1 1987 1997 My Story:

More information

How to manage a patient with short QT syndrome?

How to manage a patient with short QT syndrome? How to manage a patient with short QT syndrome? Torino, 27 ottobre2012 Carla Giustetto Division of Cardiology University of Torino QT 280 ms QTc 260 ms Narrow, tall and peaked T waves High incidence of

More information

In Whom and When Should Atrial Fibrillation Ablation be Considered?

In Whom and When Should Atrial Fibrillation Ablation be Considered? In Whom and When Should Atrial Fibrillation Ablation be Considered? Christian de Chillou, MD, PhD Department of Cardiology University Hospital Nancy, France ESC 2010 Stockholm, August 30. 2010 2 In Whom?

More information